Looks like they will report cash on hand in excess of 62M. They could also realize over the next 12 months 20M from Mayne if Nipent sales reach certain targets and 23M from JNJ Cilag on Dacogen targets. I would guess that this milestone on Dacogen would be tied to EU approval of Dacogen for MDS. I see that application being filed before yearend. There are several sites where new Dacogen users can get feedback and knowledge about the drug. Looks to me the drug is very effective and little side affects. I found that pretty encouraging and saw no negative reviews. There are a few posts where the person was using a competitor drug and his doctor switch him to dacogen and he reported immediate benefits.